2012, Number 5
<< Back Next >>
Gac Med Mex 2012; 148 (5)
Prevalence of cardiovascular risk factors in Balearic workers apparently healthy
López-González ÁA, Angullo ME, Román RM, Vicente-Herrero MT, Salvá MT, Ricci-Cabello I
Language: Spanish
References: 31
Page: 430-437
PDF size: 95. Kb.
ABSTRACT
Background: the prevalence of cardiovascular risk factors is well known in the general population. The aim of our study is to determine the prevalence of unknown major cardiovascular risk factors, in an apparently healthy Balearic working population.
Method: data were obtained to 3,035 people randomly selected and with unknown previous diagnosis of hypertension, diabetes or hypercholesterolemia. To compare proportions we used the χ
2 test and the t-Student test for comparison of means.
Results: the prevalence of unknown hypertension in men was 20.6%, hypercholesterolemia 11.6% and 2.6% diabetes. The prevalence of unknown hypertension, hypercholesterolemia and diabetes in women were 8.3, 5.4 and 0.8%, respectively. All cardiovascular risk factors except low HDL-cholesterol were more prevalent in men. 14.4% of men and 5.5% of women met metabolic syndrome.
Conclusions: there is a very high prevalence of cardiovascular risk factors in the working population considered theoretically healthy. This highlights the important role in this field from the occupational health units to make them emerge.
REFERENCES
Bertomeu V, Castillo-Castillo J. Situación de la enfermedad cardiovascular en España. Del riesgo a la enfermedad. Rev Esp Cardiol. 2008;8 Suppl E:2-9.
Instituto Nacional de Estadística. Defunciones según la causa de muerte 2009. Instituto Nacional de Estadística. Madrid. 2011. Disponible en: http:// www.ine.es.
Diagnòstic de salut a les Illes Balears. Govern de les Illes Balears. Conselleria de Salut i Consum. 2011. Disponible en: http://www.caib.es/ sacmicrofront/archivopub.do?ctrl=MCRST2305ZI99576&id=99576.
Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-7.
Critchley JA, Capewell S. Withdrawn: smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2012;2:CD003041.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
American Diabetes Association: standards of medical care in diabetes – 2006. Diabetes Care. 2006;29 Suppl 1:4-42.
Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus – A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007;30:162-72.
Gabriel R, Alonso M, Segura A, et al. Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE. Rev Esp Cardiol. 2008;61(10):1030-40.
Rigo-Carratalá F, Frontera G, Llobera J, Rodríguez T, Borras I, Fuentespina E. Prevalencia de factores de riesgo cardiovascular en las Islas Baleares (estudio CORSAIB). Rev Esp Cardiol. 2005;58(12):1411-9.
Grau M, Elosua R, Cabrera de León A, et al. Factores de riesgo cardiovascular en España en la primera década del siglo XX: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Rev Esp Cardiol. 2011;64(4):295-304.
Cabeza E, Artigues G, Pujol A, Tortella G, Yañez A. Encuesta de salud de les illes Balears 2007 (ESIB07). Conselleria de Salut i Consum. Govern de les illes Balears. Disponible en: http://www.caib.es/sacmicrofront/ contenido.do?mkey=M10011108173411152056&lang=CA&co nt=15844
Sánchez-Chaparro MA, Román-García J, Calvo-Bonacho E, et al. Prevalencia de factores de riesgo vascular en la población laboral española. Rev Esp Cardiol. 2006;59(5):421-30.
Pérez-Noriega E, Soriano-Sotomayor MM, Lozano-Galindo V, Morales Espinoza ML, Luz LM, Rugerio MA. Factores de riesgo cardiovascular en población adulta aparentemente sana de la ciudad de Puebla. Revista Mexicana de Enfermería Cardiológica. 2008;16(3):87-92.
Consenso SEEDO’2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2000;115:587-97.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A Joint Interm Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
Baena-Díez JM, Del Val-García JL, Tomàs-Pelegrina J, et al. Cardiovascular disease epidemiology and risk factors in primary care. Rev Esp Cardiol. 2005;58(4):367-73.
Pineda M, Custardoy J, Andreu MT, Ortín JM, Cano JG, Medina E; Grupo de Investigación Clínica del Sureste (GICS). Estudio de prevalencia de factores de riesgo cardiovascular en un área de salud. Aten Primaria. 2002;30:207-13.
Balkau B, Deanfield JE, Després JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007;116(17):1942-51.
Poley-García JJ, Costa-Ferrer A, Conget-Donlo I. Prevalencia y distribución de los factores de riesgo cardiovascular en la población de un área metropolitana. Rev Clin Esp. 2000;200:543-7.
Nebot M, Borrell C, Ballestín M, Villalbí JR. Prevalencia y características asociadas al consumo de tabaco en población general en Barcelona entre 1983 y 1992. Rev Clin Esp. 1996;196:359-64.
Alcántara PA, Aroca MD, Menárguez JF, Alcaraz J, Herranz-Valera JJ. El tabaco: factor de riesgo en una zona de salud. Aten Primaria. 1995;16:43-7.
Bellido J, Martín JC, Dueñas A, Mena FJ, Arzúa D, Simal F. Hábito tabáquico en una población general: descripción de la prevalencia, grado de consolidación y fase de abandono. Arch Bronconeumol. 2001;37:75-80.
Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-50.
McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28:385-90.
Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165: 2644-50.
Martínez J, Franch J, Romero J, Cánovas C, Gallardo A, Páez M. Prevalencia del síndrome metabólico en la población adulta de Yecla (Murcia). Aten Primaria. 2006;38(2):72-81.
Cabré JJ, Martín F, Costa B, et al. Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. BMC Public Health. 2008;8:251.
Alegría A, Cordero A, Laclaustra M, et al. Prevalencia de síndrome metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol. 2005;58(7):797-806.
Séculi E, Brugulat P, Medina A, Juncà S, Tresserras R, Salleras L. La detección de factores de riesgo cardiovascular en la red reformada de atención primaria en Cataluña. Comparación entre los años 1995 y 2000. Aten Primaria. 2003;31(3):156-62.
Sani MU, Wahab KW, Yusuf B, Gbadamosi M, Johnson OV, Gbadamosi A. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population – A cross sectional study. BMC Research Notes. 2010;3:11.